BioSpace News Archive

Career Advice

6 Ways to Find Out Why You Didn’t Get the Job Offer

While it’s unlikely that you’ll get the answers you want to all of your questions, there are still appropriate ways to approach your interviewers or the employer and find out as much as you can about their decision.

October 9, 2018
·
5 min read
·
Editorial Staff
Policy

apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent β-Thalassemia

pceth Biopharma GmbH congratulates its partner bluebird bio on the acceptance and validation of its market authorization application by the European Medicines Agency (EMA).

October 9, 2018
·
3 min read
BioCapital

CureSearch for Children’s Cancer Announces Research Award Opportunities

Up to $7 million in research awards will accelerate the development of better, less-toxic children’s cancer treatments

October 9, 2018
·
1 min read
Drug Development

Retrophin to Present Long-Term Data from Phase 2 DUET Study of Sparsentan in FSGS at ASN Kidney Week 2018

Retrophin, Inc. today announced that it will present new data examining the long-term effects of sparsentan in focal segmental glomerulosclerosis (FSGS), at the American Society of Nephrology (ASN) Kidney Week 2018.

October 9, 2018
·
6 min read
New biopharmaceutical company Sitryx launches with $30 million fundraising to develop disease modifying therapeutics in immunometabolism

Fast-emerging area of research with potential to treat severe diseases including cancer and autoimmune conditions

October 9, 2018
·
5 min read
Genetown

MilliporeSigma’s Novel Chemiflex™ Raw Materials Program Solves Regulatory Compliance Challenges in Small Molecule Drug Manufacturing

Bridges the raw material qualification gap, simplifying scale-up to cGMP manufacturing of active pharmaceutical ingredients

October 9, 2018
·
1 min read
Bio NC

EpiCypher SNAP-ChIP® technology poised to transform market for histone PTM antibodies

A recently published report in Molecular Cell validates the use of EpiCypher’s proprietary SNAP-ChIP® technology for profiling antibody specificity and sensitivity.

October 9, 2018
·
1 min read
Business

Merck’s Frazier Joins Growing List of Pharma CEOs Attacking Drug Rebates

Kenneth Frazier, chief executive officer of Merck, speaking with the Economic Club of New York, joined a growing list of pharmaceutical chiefs in criticizing the role of middlemen in rising drug prices.

October 9, 2018
·
3 min read
·
Mark Terry
Policy

Drug Prices Mostly Continue to Climb, Despite Trump’s Promises

The AP in a recent report notes that drug price increases “slowed somewhat and were not quite as steep as in past years.” But overall, there has been no “massive” drug price cuts.

October 9, 2018
·
5 min read
·
Mark Terry
The Importance of Diversity in Clinical Trials (Because Right Now, It’s Lacking)

Although race is thought of as a social concept, ‘there’s growing evidence that, whether for environmental or genetic reasons, drugs may have different effects on different populations.’

October 9, 2018
·
6 min read
·
Chelsea Weidman Burke